EPW
IRWD icon

Evolve Private Wealth’s Ironwood Pharmaceuticals IRWD Stock Holding History

Evolve Private Wealth’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$787K Buy
186,864
+171,397
+1,108% +$661K 0.05% 357
2026
Q1 		$54.3K Buy
15,467
+658
+4% +$2.7K ﹤0.01% 988
2025
Q4 		$49.9K Buy
+14,809
New +$38.5K ﹤0.01% 923

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Evolve Private Wealth's IRWD Position: Q2 2026 in Review

Evolve Private Wealth increased its Ironwood Pharmaceuticals (IRWD) stake by 1,108% in Q2 2026, buying an estimated $661K and bringing the position to 186,864 shares worth $787K. The position accounts for 0.05% of the portfolio, ranked #357.

Evolve Private Wealth first reported a position in IRWD in Q4 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Evolve Private Wealth held 186,864 shares of Ironwood Pharmaceuticals worth $787K as of Q2 2026.
  • Evolve Private Wealth bought 171,397 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $661K.
  • Ironwood Pharmaceuticals made up 0.05% of Evolve Private Wealth's portfolio in Q2 2026, its #357 holding.
  • Evolve Private Wealth first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.